XBIT Earnings & Financial Statements
XBiotech Inc.
$2.18
+$0.02(+0.93%)
56
Overall
60
Value
83
Tech
26
Quality
Market Cap
$65.85M
Volume
40.43K
52W Range
$2.09 - $3.44
Target Price
$18.00
XBIT earnings and financial statements: XBiotech Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
XBIT Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | - | - | $4.01M | $18.39M |
| Cost of revenue | - | - | - | $651.0K | $5.82M |
| Operating income | -$55.69M | -$42.47M | -$37.51M | -$34.49M | -$25.08M |
| EBITDA | -$43.53M | -$36.01M | -$22.57M | -$31.88M | -$22.43M |
| Net income | -$45.54M | -$38.53M | -$24.56M | -$32.90M | -$17.41M |
| EPS (diluted) | $-1.49 | $-1.26 | $-0.81 | $-1.08 | $-0.58 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $150.08M | $199.09M | $226.62M | $246.10M | $275.18M |
| Total liabilities | $9.73M | $16.82M | $7.77M | $5.70M | $5.79M |
| Shareholders’ equity | $140.35M | $182.27M | $218.85M | $240.40M | $269.38M |
| Cash and equivalents | $125.55M | $172.68M | $200.02M | $157.31M | $236.98M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$39.92M | -$30.96M | -$18.73M | -$14.82M | $69.44M |
| Capital expenditure | -$289.0K | -$1.30M | -$362.0K | -$585.0K | -$3.52M |
| Free cash flow | -$40.21M | -$32.27M | -$19.09M | -$15.41M | $65.92M |
| Dividends paid | - | - | - | - | $75.00M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XBIT | $2.18 | +0.9% | 40.43K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |